INTRODUCTION
The increasing use of antibiotics since their discovery is not without its penalties. The dawn of antimicrobial resistance, alongside antibiotic induced super infections, such as Clostridium difficile (C. difficile) associated diarrhoea, has called for more strict and robust antimicrobial stewardship. Antimicrobial stewardship aims to promote the rational use of antibiotics by ensuring that the most appropriate antibiotic is chosen, at the correct dose by the correct route for the correct time 1 .
One aspect of antimicrobial stewardship is the application of antibiotic intravenous to oral switch guidelines 2 . Since the late 1980's there has been a plethora of research into the benefits of employing an early intravenous to oral switch policy for antibiotics. These benefits include the facilitation of early discharge from hospital 3 , a reduced risk of cannula associated adverse events 4 , reduced spend on medication 5, 6 , and a shorter time required for administering the medication. These benefits are observed due to a reduction in the course length of intravenous antibiotics. For example, in the studies by Ramirez et al 3 and McLaughlin et al 5 , the implementation of antibiotic guidelines facilitating early intravenous to oral switch was associated with a 29-33% reduction in the course lengths of intravenous antibiotics in patients with community acquired pneumonia. The implementation of IV to oral switch antibiotic guidelines has been shown to speed up the time taken from when the patient is first eligible for oral antibiotics to the prescription being changed 7 . Furthermore shorter intravenous courses prior to oral therapy in medical patients, with predominantly respiratory infections, have been shown to reduce the median duration of hospital stay from 13 to 10 days 5 . There has been some speculation that this may decrease the incidence of healthcare associated infections such as C. difficile 8 although there is no evidence to directly support this correlation in the literature.
A potential risk of the intravenous to oral switch may include the switch occurring too early, resulting in an inadequate treatment of the infection and thus clinical deterioration. Ramirez et al 3 reported only one treatment failure (following early intravenous to oral switch) out of 118 patients with community acquired pneumonia; however this patient had multiple respiratory pathologies. In this case intravenous therapy was resumed. In another study 7 of 66 patients undergoing early intravenous to oral switch for community acquired pneumonia were readmitted but none were for infectious causes 6 .
It is important to acknowledge that the intravenous to oral switch is not appropriate in all patients. For treatment of certain infections, such as endocarditis and osteomyelitis, high antibiotic tissue concentrations are needed and therefore intravenous therapy is essential. An intravenous to oral switch in these infections would likely have a significant negative clinical impact. Alternatively there are some oral antibiotics which have a high bioavailability, thus the equivalent intravenous formulation appears costly to use with no extra clinical benefit. Sequential therapy programs have been undertaken with quinolones for this reason showing that significant cost savings can be made by reducing the usage of intravenous formulations by 60% 9 . In this study the intravenous route was reserved only for the seriously ill or those with intestinal diseases that prevented sufficient oral absorption.
It is therefore essential that antibiotic intravenous to oral switch guidelines include various criteria to ensure that a switch is appropriate. These range from acknowledging clinical improvement to assessing the safety and practicality of the oral route.
Consideration must also be made to which oral antibiotic would be most appropriate as in some cases there are not comparable oral formulations. Pharmacists are well placed to offer advice on available formulations and pharmacokinetic considerations in switching to oral equivalents. They also play roles as antimicrobial specialist pharmacists involved in designing and implementing the guidelines as well as dispensing pharmacists who may be required to enforce the restrictions on antibiotic supply outlined by guidelines 10 . Antibiotic restriction may be one method of regulating the use of intravenous antibiotics however multidisciplinary engagement is likely to be essential for trust-wide guideline adherence. Physician involvement in intravenous to oral switch programmes has previously been thought to be vital in clarifying the legitimacy of the programme to medical colleagues less they believe it to be simply a cost-saving exercise led by pharmacists 10 . Whilst barriers reported by doctors concerning optimal antibiotic use for community acquired pneumonia have included a lack of familiarity with the guideline, belief that intravenous therapy is more efficacious, concern about re-infection and a desire to let senior physicians make the decision 11 , the barriers to intravenous to oral switch guideline adherence have received little attention in the literature.
At a large teaching hospital in South West England, a guideline for intravenous to oral switch was developed in 2007, taking into consideration the evidence discussed above. However, a re-audit completed in 2009 demonstrated that there was persistent poor adherence to the guideline 12 . The aim of this study, completed in 2010-2011, was therefore to identify the barriers of doctors, nurses and pharmacists to adhering to the guideline and to explore their possible solutions to overcome these barriers.
Due to the number of healthcare professionals involved in antibiotic therapy, it was decided that a multidisciplinary consensus was required on the prohibitive and enabling contributors to the timely switch of intravenous to oral antibiotics in accordance with local and national guidelines.
METHODS
The study was conducted at University Hospitals Bristol NHS Foundation Trust, a large teaching hospital and tertiary referral centre for cardiology, paediatrics and oncology. The North Somerset and South Bristol Research Ethics Committee deemed the study to be service development and hence ethical approval was not required.
The method comprised a three round Delphi study (one explorative and two iterative rounds) which was initiated in late spring 2010 and semi-structured interviews. The latter were conducted in parallel to the Delphi study as it is generally recognised that the Delphi technique should not be used in isolation 13 . This approach was chosen in order to generate a consensus across disciplines, to allow the participation of various healthcare professionals irrespective of shift-working and to prevent bias and social pressures between profession and grade.
Delphi Study: The Expert Panel
The expert panel was purposively sampled from qualified doctors, nurses and pharmacists who had daily involvement with intravenous antibiotic prescriptions. Ten participants from each profession were invited to participate in line with previous Delphi studies in the healthcare setting 14 . The participants were selected to evenly represent a variety of grades over the 4 directorates: oncology and haematology, medicine, surgery and cardiology (table 1) . Random selection of these staff was not possible due to shift working, incomplete staffing lists, an ever changing work force and in some cases too few staff in certain positions for example pharmacists in cardiology. It was decided not to include microbiologists as, although they have expert knowledge in the field of antibiotics, their role as consultants limits their daily exposure to the practicalities of the intravenous to oral switch guideline at ward level. Including "illusory expertise" in the expert panel has previously been cited as a basic pitfall of the Delphi technique 15 .
The expert panel were advised that during the study they should not discuss the intravenous to oral switch guideline with other panel members. They were encouraged to contact the investigator if more time was required to complete each round or if any clarification was needed. All participants were sent correspondence via e-mail outlining information about the study prior to the first round. Completion and return of the study material was taken to imply consent as fully informed consent, in the case of questionnaires, can often only be achieved once the participants have examined the material 16 .
Delphi First Round
The correspondence for the first and subsequent rounds was distributed by e-mail with a two week deadline for responses. All rounds were piloted by a pharmacist independent of the expert panel and any ambiguities were resolved prior to distribution.
In round one, free text responses were invited to the following open questions:
1) What barriers prevent a switch from the intravenous to oral route in line with guideline suggestions? 2) What could be done to improve adherence to the antibiotic intravenous to oral switch guideline based on the barriers you have identified?
The resulting comments were anonymised and split into two categories: barriers to adherence and solutions to poor adherence. Each category was thematically analysed by the principal investigator, the senior antimicrobial pharmacist and the clinical pharmacy manager. Identical themes were grouped together and formatted into statements of around 20-25 words which has been shown to encourage optimal consensus in Delphi studies 15 .
Delphi Second Round
The Delphi statements resulting from round one were formulated into a questionnaire in which the expert panel were asked to rate the importance of each statement on a five point ordinal scale, from irrelevant to very important, as used by Roos and Weardon
17
. In addition to rating the level of agreement with each statement, the members of the expert panel were invited to justify their response or comment on each statement. They were advised that these would be anonymised and fed back to the expert panel in subsequent rounds.
Delphi Third Round
The purpose of the third round is to allow the members of the panel to re-score each statement based on the comments and group position from the previous round in order to generate greater consensus. The responses to round two were collated and presented in the final questionnaire ( Figure 1 ). A linear scale, which is well described in previous Delphi studies 18, 19 , was used to present the results of the second round to the panel in the third round questionnaire. All justifications and comments were anonymised and included without editing. As there were no requests for clarification of any statement and no requests for inclusion of alternative themes, the statements remained unchanged between rounds.
Data Analysis
Data from members of the expert panel who did not complete all three rounds were excluded before analysis. The resulting data from Delphi rounds two and three were analysed using Microsoft ® Excel ® by quantifying each response (1 equated to irrelevant; 5 to very important). The ordinal nature of the data dictated that the median be used to describe the response of the panel [18] [19] [20] . As in previous Delphi studies, the interquartile range (IQR) was used to describe the degree of agreement within the expert panel 17, 19 with an IQR of 1 or less representing consensus 17 . Stability between rounds was determined by a change of less than 15% which has been considered the natural level of oscillation between consecutive Delphi rounds 21 . The differences in response between each profession were analysed using IBM SPSS Statistics (SPSS ® ) Version 16. A Mann Whitney test was used to compare the response of doctors and pharmacists.
Interviews
Semi-structured interviews were conducted with doctors, nurses and pharmacists (who were not invited to participate in the Delphi study) to further explore the barriers to guideline adherence and solutions to poor adherence. The Delphi participants were not interviewed because individual ideas may have been lost to group consensus by nature of the Delphi process. Non-responders were not interviewed as it was presumed that they no longer wished to participate. One participant was purposively sampled from each of the three professions in turnuntil no new themes emerged.
The initial interview schedule was informed by the responses to the first round of the Delphi study, the literature and the aims and objectives of the study. The original interview schedule was piloted on a pharmacist and any points of ambiguity resolved. The interviews were recorded and transcribed verbatim into Microsoft ® Word ® . The final transcript accuracy was checked by the principal investigator. The interviews were thematically analysed by the principal investigator and a coding tree was developed for each question. The themes identified from the interviews were then compared and contrasted with the Delphi study results.
RESULTS

Delphi
Of the 30 members of the expert panel invited to participate, one declined after the introductory letter. Of the remaining 29 participants, 16 (55%) completed round one and 13 (45%) completed all rounds. The resulting expert panel comprised four doctors and nine pharmacists; no nurses completed all rounds (table 1) .
Following round one, 18 statements concerning barriers and 17 statements concerning solutions were formulated and entered into the round two questionnaire template. The statements remained unchanged throughout rounds two and three as there were no requests for clarification or rewording.
Barriers
Consensus was achieved for 14 statements (78%) following round three (table 2) . The highest level of agreement with the median was achieved for statement B1 (76.9%). The level of consensus in round three, determined by a reduced IQR, improved for five statements (B1, B8, B9, B11 and B13) when compared with round two. Stability, less than 15% change between rounds two and three, was reached for all statements except statement B1.
Solutions
Consensus was achieved for 14 statements (82%) following round three (table 3) . The highest level of agreement with the median was achieved for statement S12 (76.9%). The level of consensus improved for two statements (S4 and S11) between rounds however there was a divergence of opinion (increase in IQR) for S13. Stability between rounds was reached for all statements.
Interprofessional differences
There was no significant difference (p>0.05) between the median ratings of doctors and pharmacists for all but one statement. Statement B10 showed a difference of opinion between doctors and pharmacists (p=0.023) with doctors appearing to vote lower (two choosing irrelevant) in the raw data.
Interviews
Seven interviews were conducted including three with doctors, two with pharmacists and two with nurses at which point no new themes emerged. The barriers to guideline adherence were divided into three categories as identified previously in describing interview responses to questions concerning guideline adherence 
DISCUSSION
The application of a Delphi study and semi-structured interviews was successful in identifying barriers to the antibiotic intravenous to oral switch guideline and solutions to poor guideline adherence. Within the Delphi study, consensus was achieved for 26 out of 35 statements, with the most important barrier being a lack of appropriate antibiotic review at the weekend and the most important solution to raise guideline awareness.The findings of the Delphi study were in general well supported by those themes identified by the interviews. The combination of the Delphi technique with semistructured interviews was advantageous, especially with respect to more specific solutions on how to overcome the barriers to guideline adherence were identified in the interviews. The interviews also provided an opportunity for the views of nurses to be represented. It must also be recognised that by the nature of the Delphi technique, specific ideas from a few individuals may have been marginalised in favour of group consensus.
. Participant fatigue is a well recognised limitation of the Delphi study 22 . The lack of nurses in the final Delphi expert panel limits the findings to those of the pharmacy and medical profession although the two nurses interviewed did identify how they could contribute in this area. It is possible that the method of communication by e-mail was not suitable for this group as computer access at ward level is restricted. Whilst the resulting expert panel comprised more pharmacists than doctors, which may have skewed the median, statistically there was no difference between professions except for statement B7. The anonymity of the panel encouraged all participants to judge the comments published between rounds with equal merit. Statement B1 did not achieve stability using the 15% change rule following round three, however it was decided that participant fatigue would be too great to benefit from distributing a fourth round containing only one statement. The use of IQR alone as a method for determining consensus is restrictive as it does not identify the few cases demonstrating bipolar or plural distributions i.e. where there is strong consensus in a particular group of participants 23 . One statement ("the initial indication for the antibiotics was not recorded by the prescribing doctor") has been noticed to show a bipolar distribution during data analysis. Here, equal participants selected important and not important with pharmacists and doctors represented equally in both groups. Using the IQR does not give a robust way to identify all of these alternative distributions.
The most important barrier to antibiotic intravenous to oral switch guideline adherence was perceived to be lack of appropriate review at the weekends. Methods for adequate provision of information with which to inform a switch to oral antibiotics at the weekend should be investigated in the future. Due to limited medical staffing at the weekend it may be necessary to look further afield than simple provision of information to a conditional switch plan which is documented in the medical notes and may be supported in certain areas by a patient group direction.
All of the statements (n=7) where consensus was not reached concerned specific roles for a particular profession. This may be due to differences between the perception of each profession for their own and the other professions responsibilities. Such differences could be a draw-back of the method used but may also highlight that individuals are not aware of the scope of each profession concerning the intravenous to oral switch guideline.
There were no statements (barriers or solutions) pertaining to the involvement of nurses in the antibiotic intravenous to oral switch from the Delphi study. This is possibly due to the lack of nurse respondents to the Delphi which may cast doubt over their perceived role in the switch process. There is little information in the literature concerning nurses attitudes towards the intravenous to oral switch process and so it is difficult to postulate whether the Delphi results would be different with nurse involvement. However the nurses interviewed were clear in their roles of highlighting those patients on intravenous antibiotics for over 48 hours and prompting medical review. Gillespie et al 24 showed that the involvement of nurses in antimicrobial stewardship education sessions and awareness campaigns improved awareness of resistance from 59% to 79% and of line infection due to antibiotic therapy from 38% to 70%. This correlated to a reduction in line days for 3 of the 6 wards studied and a reduction from 3 line-related infections to 2 after the intervention. It is apparent that nurses are well placed to identify intravenous antibiotic prescriptions that are due for review due to regular medication rounds and patient observation monitoring throughout the day. Engaging the nurses in antimicrobial stewardship using these strategies is likely to be necessary at the study hospital in order to improve adherence to the IV to oral switch guideline.
The interviews alone revealed that doctors are sometimes unaware of which patients are on intravenous antibiotics and therefore those to whom the guideline applies. This view did not emerge through the Delphi study, perhaps through concern that other healthcare professionals would deem this sub-standard practice. The solutions identified through interviews included several point of switch reminders such as stickers affixed to the medication chart, which have been shown to reduce the average course of intravenous antibiotics from over 10 days to 8.4 days 25 if placed on day 7. The role of pharmacists in the antibiotic intravenous to oral switch has previously ranged from design and implementation of switch guidelines 5 to prompting review by doctors. Over 60% of the expert panel felt that pharmacy staff are not confident to encourage the intravenous to oral switch (statement B10). This is consistent with previous literature which showed that 58% of pharmacists agreed that a 'lack of training/confidence' was a reason for not applying the policy 26 . Out of the four doctors one felt that this was an important barrier whilst the other three chose 'unsure'. This highlights an area where pharmacists may benefit from specific training with support from specialist antibiotic pharmacists.
The proposal that all intravenous antibiotics should be automatically switched from the intravenous to oral route at 48 hours via the Delphi study met with significant opposition. Comments received from a registrar (with an interest in infectious disease) suggest that this approach would compromise patient safety "patients with conditions like endocarditis should not suffer due to doctors poor prescribing habits". This view highlights that guidelines need to balance promoting good prescribing practice and upholding high standards of patient care whilst not letting poor prescribing go unchallenged. The use of antibiotics in less serious infections however has been shown to benefit through the use of a patient group direction (PGD) where nurses can facilitate the switch reducing the median IV antibiotic therapy from 4 to 3 days for uncomplicated cellulitis in an outpatient setting 27 . Whilst the use of a PGD effectively empowers nursing staff to act on the guideline more work is required to determine if this approach would be as successful in secondary care.
Engaging guideline users is an ever growing challenge due to the multitude of clinical guidelines released every year. Recent measures of good antimicrobial stewardship have encouraged the application of around seven different guidelines, one of which is an antibiotic intravenous to oral switch guideline 2 . Methods for engaging guideline users proposed via the Delphi study included education sessions using interactive case studies (statement S7), education on the benefits of intravenous to oral switch (statement S6) and making the guideline more accessible on wards (statement S2). The interview findings mirror these solutions and introduce the additional idea of providing feedback to each consultant team on guideline adherence data and specific benefits such as cost saving. It has been shown that facilities with good clinical guideline adherence have better evidence of timely, individual, non-punitive and customisable audit feedback than lower performing facilities 28 . Doctors have previously agreed that this approach along with encouragement from senior doctors is likely to encourage the adherence to guidelines 29 .
CONCLUSIONS
The study has been successful in identifying several barriers to guideline adherence and discovering several solutions that may improve adherence. The most important barrier highlighted was the difference in practice between weekday and weekend working. This should be the focus of effort in attempting to improve adherence to the intravenous to oral switch guideline initially. The most important proposed solution was perceived to be improving guideline awareness through various methods targeting all grades of doctors as well as further engaging nursing staff. Such solutions should be investigated individually in future work to determine which may have a lasting impact on guideline adherence.
Whilst this study concentrated on the intravenous to oral switch guideline, some of the barriers and solutions identified are transferable to increasing adherence to all guidelines. The challenge to increase adherence to guidelines will only increase, as it is clear from the interviews that some healthcare professionals already feel overwhelmed, by the ever emerging barrage of clinical guidelines. This reinforces the need for healthcare professionals to produce concise well sign-posted guidelines which are efficiently disseminated to all professions involved. "On a busy ward you just think they're on an antibiotic and you kind of don't look at how it's being given unless the nurses flag it up and say 'do we really need to give it IV?'" (Dr3S) c) Perception that oral antibiotics are inferior:
"They're not as effective, the oral antibiotics, that would be the main concern." (Dr 3S) a) Low priority: 
Dr, doctor; Ph, pharmacist; N, nurse; M, medical; S, surgical Highlighted themes were unique to the interviews 
Comments from previous rounds:
The frequency with which antibiotics review dates are omitted is decreasing, so I don't believe it is this that is preventing the IV to oral switch in the majority of cases. 0 2 * 2 7 4
Comments on this round: Please enter comments here Figure 1 : Example of the format for the third round questionnaire including results from round 2. The view taken by the participant in the previous round is indicated with an asterisk, the median value of the expert panel is shaded.
